Form 4: Veracyte Executive Phillip G. Febbo Reports Stock Transactions
SEC Form 4 Filing
Phillip G. Febbo, Chief Scientific & Medical Officer of Veracyte, Inc., reports acquisition of shares through vesting of restricted stock units and subsequent withholding of shares for tax obligations.
Summary
- On February 27, 2025, Phillip G. Febbo acquired 30,589 shares of Veracyte common stock upon the vesting of performance-based restricted stock units (PSUs).
- Also on February 27, 2025, 15,672 shares were withheld to cover tax obligations related to the PSU vesting at a price of $33.84 per share.
- On March 2, 2025, an additional 6,754 shares were withheld to cover tax obligations related to the vesting of restricted stock units at a price of $34.76 per share.
- Following these transactions, Febbo directly owns 90,577 shares of Veracyte common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing primarily reflects routine stock transactions related to executive compensation and tax obligations. The vesting of PSUs is a positive sign, but the tax withholding is a standard procedure.
Positives
- The vesting of performance-based restricted stock units indicates the achievement of certain performance goals set by Veracyte's Board of Directors.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests between management and shareholders.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Acquisition of 30,589 shares of common stock upon vesting of PSUs and withholding of 15,672 shares for tax obligations. |
| 03/02/2025 | Withholding of 6,754 shares of common stock for tax obligations related to vesting of restricted stock units. |
| 03/03/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.